Innovent Biologics Sells Minority Stake in Subsidiary
Company Announcements

Innovent Biologics Sells Minority Stake in Subsidiary

Innovent Biologics (HK:1801) has released an update.

Innovent Biologics announced a strategic move involving the sale of a minority stake in its subsidiary, Fortvita, to Lostrancos for $20.5 million. This transaction will reduce Innovent’s ownership from 100% to 79.61%, marking a significant financial maneuver aimed at unlocking capital and potentially enhancing shareholder value.

For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskInnovent Biologics Ends Proposed Subscription Agreement
TipRanks HongKong Auto-Generated NewsdeskInnovent Biologics Reports Strong Revenue Growth in Q3 2024
TheFlyInnovent Biologics says picankibart phase 2 study met primary endpoint
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App